bpc-157 clinical trials human 2025 Discover BPC-157: its first randomized, placebo-controlled trial is now recruiting. Thirty years of preclinical data and exactly one prior human study defined the evidence base until now. A systematic review The Stable Gastric Pentadecapeptide BPC

HUBERMAN: And I just want to return to the point I made earlier, which is that, you know, BPC-157 is typically taken in these dosages of about 300 to 500 micrograms, you know, two to three times per week, maybe even five days per week

Refer to the batch-specific COA for exact peptide content

GMP-Certified Manufacturing Every product made in an FDA-registered, GMP-compliant facility, backed with certifications, chemists & lab tests

This extends 100mg to roughly 10 weeks at 2mg per dose

It spiced up our love life in ways I never expected because the growth was gradual

Vendors use this phrasing to market the peptides as not for human consumption to try and get around the Medicines Act